Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,123,479 | 682,162 | 983,705 | 1,981,872 | 1,146,290 |
| Cost of Goods | 73,040 | 202,739 | 343,768 | 902,639 | N/A |
| Gross Profit | 1,050,439 | 479,423 | 639,937 | 1,079,233 | 1,146,290 |
| Operating Expenses | 597,684 | 729,093 | 1,207,216 | 1,724,608 | 2,832,866 |
| Operating Income | 452,795 | -248,931 | -566,511 | -644,736 | -1,686,576 |
| Interest Expense | 22,547 | 20,075 | 14,416 | 19,880 | 21,127 |
| Other Income | 11,919 | 92,391 | 37,896 | 10,969 | -6,833 |
| Pre-tax Income | 442,167 | -176,615 | -543,031 | -653,647 | -1,714,536 |
| Income Tax | 1,865 | 10,884 | 2,031 | 4,292 | 29,215 |
| Net Income Continuous | 440,302 | -187,499 | -545,062 | -657,939 | -1,743,751 |
| Net Income | $440,302 | $-187,499 | $-545,062 | $-657,939 | $-1,743,751 |
| EPS Basic Total Ops | 2.72 | -1.23 | -5.41 | -8.42 | -23.44 |
| EPS Basic Continuous Ops | 2.72 | -1.23 | -5.41 | -8.42 | -23.44 |
| EPS Diluted Total Ops | 2.58 | -1.23 | -5.41 | -8.42 | -23.44 |
| EPS Diluted Continuous Ops | 2.54 | -1.23 | -5.41 | -8.42 | -23.44 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.23 | -5.41 | -8.42 | -23.44 |
| EBITDA(a) | $480,408 | $-200,435 | $-525,286 | $-615,682 | $-1,673,915 |